Katherine K Tassiopoulos, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 60 | 2023 | 15906 | 2.180 |
Why?
|
Infectious Disease Transmission, Vertical | 13 | 2022 | 1323 | 0.940 |
Why?
|
Meconium | 4 | 2015 | 43 | 0.810 |
Why?
|
Condoms | 3 | 2021 | 325 | 0.730 |
Why?
|
Sexual Behavior | 6 | 2021 | 1918 | 0.640 |
Why?
|
Substance Abuse Detection | 4 | 2010 | 289 | 0.610 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2017 | 1906 | 0.580 |
Why?
|
Anti-HIV Agents | 13 | 2021 | 4133 | 0.560 |
Why?
|
Cocaine-Related Disorders | 4 | 2006 | 452 | 0.520 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2022 | 2033 | 0.510 |
Why?
|
Needle Sharing | 1 | 2013 | 22 | 0.510 |
Why?
|
Viral Load | 9 | 2020 | 3281 | 0.510 |
Why?
|
Dangerous Behavior | 1 | 2012 | 67 | 0.460 |
Why?
|
Frail Elderly | 1 | 2017 | 613 | 0.440 |
Why?
|
Hair | 2 | 2006 | 445 | 0.430 |
Why?
|
Accidental Falls | 3 | 2022 | 1037 | 0.410 |
Why?
|
Data Collection | 1 | 2020 | 3319 | 0.400 |
Why?
|
Lymphocyte Subsets | 1 | 2012 | 327 | 0.400 |
Why?
|
Heroin Dependence | 3 | 2005 | 176 | 0.360 |
Why?
|
HIV Integrase Inhibitors | 2 | 2021 | 123 | 0.360 |
Why?
|
Substance Abuse, Intravenous | 1 | 2013 | 481 | 0.360 |
Why?
|
Anti-Retroviral Agents | 6 | 2019 | 1636 | 0.350 |
Why?
|
Self Disclosure | 3 | 2006 | 265 | 0.330 |
Why?
|
Medication Adherence | 5 | 2020 | 2047 | 0.320 |
Why?
|
Prenatal Exposure Delayed Effects | 5 | 2019 | 2327 | 0.300 |
Why?
|
Herpes Genitalis | 1 | 2007 | 134 | 0.290 |
Why?
|
Health Behavior | 2 | 2016 | 2616 | 0.280 |
Why?
|
Herpesvirus 2, Human | 1 | 2007 | 181 | 0.280 |
Why?
|
HIV Protease Inhibitors | 1 | 2008 | 436 | 0.280 |
Why?
|
Adolescent | 32 | 2023 | 85064 | 0.270 |
Why?
|
Substance-Related Disorders | 4 | 2021 | 4182 | 0.270 |
Why?
|
Hypercholesterolemia | 2 | 2011 | 1159 | 0.270 |
Why?
|
Longitudinal Studies | 10 | 2022 | 13635 | 0.260 |
Why?
|
Papillomavirus Vaccines | 2 | 2022 | 487 | 0.250 |
Why?
|
Occupations | 1 | 2006 | 510 | 0.250 |
Why?
|
Restaurants | 1 | 2006 | 214 | 0.240 |
Why?
|
Trichomonas Infections | 1 | 2022 | 41 | 0.230 |
Why?
|
Social Perception | 1 | 2006 | 421 | 0.220 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2015 | 4264 | 0.220 |
Why?
|
Female | 60 | 2023 | 377052 | 0.220 |
Why?
|
Trichomonas vaginalis | 1 | 2022 | 80 | 0.220 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 2941 | 0.220 |
Why?
|
Cocaine | 2 | 2006 | 994 | 0.220 |
Why?
|
Self Report | 3 | 2016 | 3409 | 0.210 |
Why?
|
Male | 50 | 2022 | 350143 | 0.210 |
Why?
|
Prevalence | 13 | 2022 | 14877 | 0.210 |
Why?
|
Adult | 33 | 2022 | 212237 | 0.210 |
Why?
|
Cohort Studies | 18 | 2022 | 40040 | 0.200 |
Why?
|
Succinic Acid | 1 | 2021 | 88 | 0.200 |
Why?
|
Cholesterol | 2 | 2019 | 2867 | 0.200 |
Why?
|
Syphilis | 1 | 2022 | 212 | 0.200 |
Why?
|
Aging | 6 | 2022 | 8352 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4388 | 0.190 |
Why?
|
Middle Aged | 29 | 2022 | 214639 | 0.190 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2022 | 2189 | 0.190 |
Why?
|
Chlamydia Infections | 1 | 2022 | 351 | 0.180 |
Why?
|
Humans | 66 | 2023 | 715594 | 0.180 |
Why?
|
Drug Resistance, Viral | 2 | 2016 | 798 | 0.180 |
Why?
|
Gonorrhea | 1 | 2022 | 307 | 0.180 |
Why?
|
Tanzania | 3 | 2009 | 1202 | 0.180 |
Why?
|
Papillomavirus Infections | 2 | 2022 | 1512 | 0.180 |
Why?
|
Hepatitis C | 2 | 2023 | 1521 | 0.180 |
Why?
|
Mental Disorders | 5 | 2019 | 6445 | 0.180 |
Why?
|
Young Adult | 14 | 2022 | 56140 | 0.170 |
Why?
|
HIV | 5 | 2023 | 1542 | 0.170 |
Why?
|
DNA, Mitochondrial | 2 | 2021 | 795 | 0.170 |
Why?
|
United States | 17 | 2021 | 67895 | 0.170 |
Why?
|
Hepatitis B | 1 | 2023 | 651 | 0.160 |
Why?
|
Prospective Studies | 16 | 2023 | 51354 | 0.160 |
Why?
|
Sexually Transmitted Diseases | 1 | 2022 | 565 | 0.160 |
Why?
|
Child | 22 | 2022 | 74413 | 0.160 |
Why?
|
Risk Factors | 17 | 2022 | 70931 | 0.150 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 14439 | 0.150 |
Why?
|
Metabolic Diseases | 1 | 2023 | 649 | 0.140 |
Why?
|
HIV-1 | 4 | 2021 | 6900 | 0.140 |
Why?
|
Antibodies, Viral | 2 | 2019 | 2993 | 0.140 |
Why?
|
Bone Diseases | 1 | 2019 | 426 | 0.140 |
Why?
|
Puerto Rico | 1 | 2016 | 354 | 0.140 |
Why?
|
Logistic Models | 6 | 2020 | 13605 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 6 | 2020 | 2582 | 0.130 |
Why?
|
Pregnancy | 14 | 2022 | 27362 | 0.130 |
Why?
|
Safe Sex | 2 | 2021 | 139 | 0.130 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 39 | 0.130 |
Why?
|
Age Factors | 8 | 2019 | 18772 | 0.130 |
Why?
|
Risk-Taking | 2 | 2011 | 997 | 0.130 |
Why?
|
Psychotropic Drugs | 1 | 2019 | 901 | 0.120 |
Why?
|
Odds Ratio | 7 | 2021 | 9977 | 0.120 |
Why?
|
Health Services | 1 | 2019 | 744 | 0.120 |
Why?
|
Treatment Failure | 1 | 2019 | 2686 | 0.120 |
Why?
|
Haplotypes | 1 | 2020 | 2883 | 0.120 |
Why?
|
Papillomaviridae | 1 | 2019 | 1139 | 0.120 |
Why?
|
Aged | 11 | 2022 | 162392 | 0.120 |
Why?
|
Prenatal Injuries | 1 | 2012 | 13 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2005 | 405 | 0.110 |
Why?
|
Fractures, Bone | 2 | 2015 | 1878 | 0.110 |
Why?
|
Caregivers | 4 | 2019 | 1925 | 0.110 |
Why?
|
Crime Victims | 1 | 2016 | 306 | 0.110 |
Why?
|
Sex Offenses | 1 | 2016 | 333 | 0.110 |
Why?
|
HIV Seropositivity | 2 | 2019 | 924 | 0.110 |
Why?
|
Socioeconomic Factors | 4 | 2015 | 7737 | 0.110 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58293 | 0.100 |
Why?
|
Premature Birth | 1 | 2022 | 1553 | 0.100 |
Why?
|
Bone Resorption | 1 | 2015 | 739 | 0.100 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39334 | 0.100 |
Why?
|
Bone Density | 2 | 2015 | 3415 | 0.100 |
Why?
|
Infant, Newborn | 7 | 2022 | 24776 | 0.100 |
Why?
|
Unsafe Sex | 1 | 2012 | 228 | 0.100 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 23385 | 0.100 |
Why?
|
Marijuana Smoking | 1 | 2013 | 251 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 2 | 2015 | 1120 | 0.100 |
Why?
|
Demography | 3 | 2019 | 1627 | 0.100 |
Why?
|
Pregnancy Trimesters | 1 | 2010 | 198 | 0.090 |
Why?
|
Gestational Age | 2 | 2015 | 3440 | 0.090 |
Why?
|
Body Size | 1 | 2012 | 465 | 0.090 |
Why?
|
Antibodies, Bacterial | 1 | 2014 | 1456 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2015 | 1511 | 0.080 |
Why?
|
Counseling | 1 | 2016 | 1511 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3071 | 0.080 |
Why?
|
Alcohol Drinking | 2 | 2013 | 3898 | 0.080 |
Why?
|
Incidence | 6 | 2019 | 20761 | 0.080 |
Why?
|
Pilot Projects | 1 | 2020 | 8079 | 0.080 |
Why?
|
Adenine | 1 | 2012 | 901 | 0.080 |
Why?
|
Population Surveillance | 2 | 2016 | 2652 | 0.080 |
Why?
|
Executive Function | 1 | 2015 | 1300 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2011 | 617 | 0.070 |
Why?
|
Lactic Acid | 1 | 2011 | 1118 | 0.070 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12495 | 0.070 |
Why?
|
Adolescent Behavior | 2 | 2013 | 1162 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8238 | 0.070 |
Why?
|
Weight Loss | 1 | 2017 | 2514 | 0.070 |
Why?
|
Motivation | 2 | 2006 | 1897 | 0.070 |
Why?
|
Quality of Life | 2 | 2023 | 11736 | 0.070 |
Why?
|
Sexual Partners | 1 | 2009 | 696 | 0.060 |
Why?
|
Psychology | 1 | 2006 | 353 | 0.060 |
Why?
|
African Americans | 1 | 2019 | 4991 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2015 | 5859 | 0.060 |
Why?
|
Radioimmunoassay | 1 | 2004 | 956 | 0.060 |
Why?
|
Mothers | 1 | 2014 | 2021 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4165 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2009 | 2015 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2011 | 1123 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2012 | 2104 | 0.060 |
Why?
|
Risk Assessment | 3 | 2020 | 23482 | 0.060 |
Why?
|
Child, Preschool | 7 | 2016 | 41184 | 0.060 |
Why?
|
Exercise | 1 | 2019 | 5428 | 0.060 |
Why?
|
Inflammation | 3 | 2023 | 10090 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5444 | 0.050 |
Why?
|
Citric Acid | 1 | 2021 | 123 | 0.050 |
Why?
|
Cultural Diversity | 1 | 2005 | 346 | 0.050 |
Why?
|
Chlamydia trachomatis | 1 | 2022 | 245 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4905 | 0.050 |
Why?
|
Massachusetts | 1 | 2013 | 8742 | 0.050 |
Why?
|
Weight Gain | 2 | 2021 | 2224 | 0.050 |
Why?
|
Alanine Transaminase | 1 | 2023 | 599 | 0.050 |
Why?
|
Neisseria gonorrhoeae | 1 | 2022 | 236 | 0.050 |
Why?
|
Chromatography, Liquid | 2 | 2015 | 960 | 0.050 |
Why?
|
Infant | 7 | 2016 | 34561 | 0.050 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 87 | 0.050 |
Why?
|
Hepatitis B virus | 1 | 2023 | 459 | 0.050 |
Why?
|
Condylomata Acuminata | 1 | 2019 | 81 | 0.050 |
Why?
|
Phenotype | 1 | 2017 | 16302 | 0.040 |
Why?
|
Integrases | 1 | 2021 | 546 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 28991 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4586 | 0.040 |
Why?
|
RNA, Viral | 2 | 2019 | 2871 | 0.040 |
Why?
|
Maternal Exposure | 2 | 2015 | 907 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2010 | 2838 | 0.040 |
Why?
|
Developing Countries | 1 | 2009 | 2727 | 0.040 |
Why?
|
Immunity | 1 | 2022 | 975 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2010 | 3974 | 0.040 |
Why?
|
Cervix Uteri | 1 | 2019 | 578 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 8950 | 0.030 |
Why?
|
Attitude to Health | 1 | 2005 | 2104 | 0.030 |
Why?
|
Hepatitis A Vaccines | 1 | 2014 | 28 | 0.030 |
Why?
|
Domestic Violence | 1 | 2016 | 175 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10660 | 0.030 |
Why?
|
Decision Making | 1 | 2009 | 3843 | 0.030 |
Why?
|
Publishing | 1 | 2022 | 806 | 0.030 |
Why?
|
Tetanus Toxoid | 1 | 2014 | 208 | 0.030 |
Why?
|
Cognition | 2 | 2021 | 6074 | 0.030 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2019 | 604 | 0.030 |
Why?
|
Child Behavior Disorders | 1 | 2019 | 818 | 0.030 |
Why?
|
Postpartum Period | 1 | 2019 | 985 | 0.030 |
Why?
|
Mental Health Services | 1 | 2005 | 1618 | 0.030 |
Why?
|
Comorbidity | 2 | 2019 | 10429 | 0.030 |
Why?
|
Mexico | 1 | 2015 | 683 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2022 | 1989 | 0.030 |
Why?
|
Drug Utilization | 1 | 2019 | 1237 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2015 | 572 | 0.030 |
Why?
|
Boston | 1 | 2006 | 9374 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2014 | 808 | 0.030 |
Why?
|
Peru | 1 | 2015 | 845 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2019 | 1395 | 0.030 |
Why?
|
Mood Disorders | 1 | 2019 | 1102 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 3946 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2023 | 1858 | 0.030 |
Why?
|
Brazil | 1 | 2015 | 1154 | 0.030 |
Why?
|
HIV Seronegativity | 1 | 2011 | 207 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 460 | 0.020 |
Why?
|
Infant, Small for Gestational Age | 1 | 2012 | 437 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2011 | 455 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2019 | 2542 | 0.020 |
Why?
|
Body Mass Index | 2 | 2019 | 12547 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2313 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2837 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 6868 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2012 | 852 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2014 | 1381 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2580 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 11098 | 0.020 |
Why?
|
Intelligence | 1 | 2011 | 900 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 62039 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 2681 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12490 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 21804 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9028 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3945 | 0.010 |
Why?
|
Urban Health | 1 | 2005 | 559 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6572 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40889 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3169 | 0.010 |
Why?
|
Child Development | 1 | 2012 | 2200 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 4449 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3725 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10600 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29253 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 5914 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2010 | 3159 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 13761 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14887 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2012 | 72448 | 0.000 |
Why?
|